紧急经皮肝穿刺出血性病变氰基丙烯酸正丁酯栓塞术。
Urgent percutaneous transcatheter embolization of hemorrhagic hepatic lesions with N-butyl cyanoacrylate.
机构信息
Department of Interventional Radiology, Medical School of Ribeirão Preto, University of São Paulo, Brazil.
出版信息
Diagn Interv Radiol. 2012 Jul-Aug;18(4):403-9. doi: 10.4261/1305-3825.DIR.5211-11.1. Epub 2012 Jan 11.
PURPOSE
To report on our clinical experience with and the success rate and safety of percutaneous transcatheter embolization with N-butyl cyanoacrylate (NBCA) as the lone primary embolic agent used for arterial embolization of hemorrhagic liver lesions.
MATERIALS AND METHODS
This retrospective study enrolled all patients who presented to the emergency room with hemorrhagic liver lesions during a two-year period and were treated by percutaneous transcatheter embolization with NBCA.
RESULTS
Eight consecutive patients were evaluated, and 13 lesions were embolized exclusively with NBCA: eight pseudoaneurysms and five active bleeds. All patients were treated successfully using percutaneous transcatheter embolization with NBCA without re-bleedings or major complications.
CONCLUSION
Percutaneous transcatheter embolization with NBCA is a safe and effective method for treating hemorrhagic lesions.
目的
报告我们应用 N-丁基氰基丙烯酸酯（NBCA）经皮经导管栓塞治疗出血性肝损伤的临床经验、成功率和安全性，NBCA 为唯一的原发性栓塞剂。
材料和方法
本回顾性研究纳入了在两年期间因出血性肝损伤就诊于急诊并接受 NBCA 经皮经导管栓塞治疗的所有患者。
结果
连续评估了 8 例患者，共对 13 个病灶进行了 NBCA 栓塞治疗：8 个假性动脉瘤和 5 个活动性出血。所有患者均成功接受 NBCA 经皮经导管栓塞治疗，无再出血或严重并发症发生。
结论
NBCA 经皮经导管栓塞治疗出血性病灶是一种安全有效的方法。
Zotero 插件